Two phase III trials on patients with mild to severe plaque psoriasis showed a highly significant difference in patients achieving itch-free status compared to controls in 12 weeks (50% in both trials compared to 32% and 27% in the vehicle groups, respectively) [ 27 ].
1
—
—